1. Home
  2. ATOS vs EHTH Comparison

ATOS vs EHTH Comparison

Compare ATOS & EHTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • EHTH
  • Stock Information
  • Founded
  • ATOS 2009
  • EHTH 1997
  • Country
  • ATOS United States
  • EHTH United States
  • Employees
  • ATOS N/A
  • EHTH N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • EHTH Specialty Insurers
  • Sector
  • ATOS Health Care
  • EHTH Finance
  • Exchange
  • ATOS Nasdaq
  • EHTH Nasdaq
  • Market Cap
  • ATOS 106.9M
  • EHTH 105.1M
  • IPO Year
  • ATOS 2012
  • EHTH 2006
  • Fundamental
  • Price
  • ATOS $0.77
  • EHTH $3.43
  • Analyst Decision
  • ATOS Strong Buy
  • EHTH Hold
  • Analyst Count
  • ATOS 3
  • EHTH 3
  • Target Price
  • ATOS $6.25
  • EHTH $9.00
  • AVG Volume (30 Days)
  • ATOS 539.9K
  • EHTH 388.9K
  • Earning Date
  • ATOS 11-12-2025
  • EHTH 11-05-2025
  • Dividend Yield
  • ATOS N/A
  • EHTH N/A
  • EPS Growth
  • ATOS N/A
  • EHTH N/A
  • EPS
  • ATOS N/A
  • EHTH 0.04
  • Revenue
  • ATOS N/A
  • EHTH $542,951,000.00
  • Revenue This Year
  • ATOS N/A
  • EHTH $4.88
  • Revenue Next Year
  • ATOS N/A
  • EHTH $3.42
  • P/E Ratio
  • ATOS N/A
  • EHTH $77.53
  • Revenue Growth
  • ATOS N/A
  • EHTH 16.79
  • 52 Week Low
  • ATOS $0.55
  • EHTH $3.18
  • 52 Week High
  • ATOS $1.36
  • EHTH $11.36
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 34.80
  • EHTH 34.44
  • Support Level
  • ATOS $0.77
  • EHTH $3.30
  • Resistance Level
  • ATOS $0.85
  • EHTH $3.97
  • Average True Range (ATR)
  • ATOS 0.05
  • EHTH 0.33
  • MACD
  • ATOS -0.01
  • EHTH -0.12
  • Stochastic Oscillator
  • ATOS 18.62
  • EHTH 8.91

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

Share on Social Networks: